Dublin, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies Market (2012 - 2017)
Research and Markets (http://www.researchandmarkets.com/research/f472jd/global) has announced the addition of the "Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 - 2017)" report to their offering.
Transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends. Global research and development Network, Innovation and Spin offs have been discussed. The report tracks regional adoption and development trends, providing strategic recommendation to stay active and compete in the market space. An impact analysis of major drivers and restraints influencing the growth of the market is mapped for five year period.
Advances in cell research and therapeutic delivery
Cell research is a major driving factor for transfection market, as more than 60% of the users are of academic institutions and researchers. Research in gene transfer is being performed in in vivo conditions for different therapeutic applications; there is a growing demand for new transfection technologies to address unmet needs for therapeutic delivery which is driving the transfection market.
Home brew Reagents restricts sale of commercial kits
Home brew reagents are still the preferred choice of reagents for transfection by researchers all over the world. Most of the researchers prepare their own reagents from their laboratory to conduct their research. This is true for most of the reagent based transfection reactions. This allows them to reduce cost involved in purchasing commercial kits.
New disruptive technologies required to address transfection in hard-to-transfect cells
Transfection is an enabler technology which is used in many cell research activities, however only few cell lines are majorly used in these experiments restricting the scope of the study. Transfection in hard to transfect cells is the need of hour and it is a major challenge. There are few upcoming transfection technologies like nucleofection and magnetofection - which are an off-shoot of electroporation, which have the potential to address these challenges but are currently cost prohibitive due to which the technologies may have a much slower uptake in the developing world.
Key Topics Covered:
2. Executive Summary
3. Transfection Technologies - Technology Landscape Analysis
4. Transfection - Market Landscape Analysis
5. Global R&D Portfolio Analysis
6. Investment/Funding Analysis
7. Transfection - Diffusion Analysis
8. Competitive Landscape
9. Opportunity Evaluation And Technology Benchmarking/Roadmapping
10. Patent Analysis
11. Analyst Insights And Recommendations
12. Company Profiles
- Altogen Biosystems
- Bio-Rad Laboratories Inc.
- Clonetech Laboratories, Inc.
- Deliverics Ltd.
- Inovio Pharmaceuticals Inc.,
- Life Technologies Corporation
- Lonza Group Ltd.
- Maxcyte, Inc.
- Mirus Bio Llc.
- Molecular Transfer Inc.,
- Oz Biosciences
- Polyplus Transfection S.A.
- Promokine Gmbh
- Promega Corporation
- Qiagen N.V.
- Roche Applied Science
- Signagen Laboratories
- Sigma Aldrich Corporation
- Thermo Fisher Scientific Inc.
- Techulon Inc.,
For more information visit http://www.researchandmarkets.com/research/f472jd/global
Source:Research and Markets